These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 25295435

  • 1. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY, Tsai GE, Wang HS, Wu YH, Chiou CC, Wu VY, Lane HY.
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [Abstract] [Full Text] [Related]

  • 2. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008121. PubMed ID: 21154393
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.
    Ann Pharmacother; 2012 May 08; 46(5):642-9. PubMed ID: 22550279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ, Fabian TJ, Saul MI, Haskett R, Coley KC.
    J Psychiatr Pract; 2013 Jul 08; 19(4):288-95. PubMed ID: 23852103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
    Jing Y, Guo Z, Kalsekar I, Forbes RA, Hebden T, Thase ME.
    Int Clin Psychopharmacol; 2013 Mar 08; 28(2):87-90. PubMed ID: 23262644
    [Abstract] [Full Text] [Related]

  • 10. Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment.
    Lin CY, Lai TJ, Wu YH, Chen PK, Lin YF, Chien IC.
    J Affect Disord; 2018 Apr 01; 230():118-124. PubMed ID: 29407535
    [Abstract] [Full Text] [Related]

  • 11. Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
    Wilson MP, Minassian A, Bahramzi M, Campillo A, Vilke GM.
    J Emerg Med; 2014 Jun 01; 46(6):808-13. PubMed ID: 24656982
    [Abstract] [Full Text] [Related]

  • 12. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
    Barbee JG, Conrad EJ, Jamhour NJ.
    J Clin Psychiatry; 2004 Jul 01; 65(7):975-81. PubMed ID: 15291687
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.
    Wen XJ, Wang LM, Liu ZL, Huang A, Liu YY, Hu JY.
    Braz J Med Biol Res; 2014 Jul 01; 47(7):605-16. PubMed ID: 24919175
    [Abstract] [Full Text] [Related]

  • 14. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR, Theodore G.
    J Manag Care Pharm; 2012 Jun 01; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [Abstract] [Full Text] [Related]

  • 15. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
    Erbe S, Gutwinski S, Bschor T.
    Psychiatr Prax; 2012 Mar 01; 39(2):57-63. PubMed ID: 22189902
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
    Philip NS, Carpenter LL, Tyrka AR, Price LH.
    J Psychiatr Pract; 2008 Jan 01; 14(1):34-44. PubMed ID: 18212601
    [Abstract] [Full Text] [Related]

  • 17. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T.
    Clin Ther; 2013 Dec 01; 35(12):1867-75. PubMed ID: 24119767
    [Abstract] [Full Text] [Related]

  • 18. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
    Olfson M, Gerhard T, Huang C, Lieberman JA, Bobo WV, Crystal S.
    Schizophr Bull; 2012 Jun 01; 38(4):845-53. PubMed ID: 21307041
    [Abstract] [Full Text] [Related]

  • 19. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T.
    J Med Econ; 2011 Jun 01; 14(6):777-86. PubMed ID: 21954966
    [Abstract] [Full Text] [Related]

  • 20. The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder.
    Bartova L, Fugger G, Dold M, Kautzky A, Swoboda MMM, Rujescu D, Zohar J, Souery D, Mendlewicz J, Montgomery S, Fabbri C, Serretti A, Kasper S.
    Int J Neuropsychopharmacol; 2022 Feb 11; 25(2):118-127. PubMed ID: 34637516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.